Physicians have conducted the first procedures using Stereotaxis’ MAGiC Sweep, the first and only robotically-navigated high-density electrophysiology (EP) mapping catheter. The procedures were recently performed by Drs. Raffaele Corbisiero and Pedram Kazemian at Deborah Heart and Lung Center in Browns Mills, N.J.

“We’re excited to be the first to demonstrate the value of robotic high-density mapping and to offer this innovation to patients,” said Dr. Corbisiero, chief of Electrophysiology at Deborah Heart and Lung Center. “The ability to create a more accurate, detailed map of complex anatomy is important in diagnosing and treating arrhythmias. We have been impressed with the catheter during our experience mapping several different arrhythmias in the atria and ventricles.”

Stereotaxis launched MAGiC Sweep in the United States after securing U.S. Food and Drug Administration clearance. The product has been submitted for regulatory clearance in Europe. Used in conjunction with Stereotaxis’ Robotic Systems, MAGiC Sweep is designed to offer rapid and highly detailed electroanatomical mapping using data collected simultaneously from 20 electrodes. It maps complex anatomy with the inherent safety of an atraumatic catheter and without the anatomic distension caused by rigid catheters, according to the company.

“Navigating MAGiC Sweep to any desired cardiac location was easy, the catheter maintained stable contact with cardiac tissue, electrogram signals were very clear, and the catheter caused no ectopy in the ventricle,” added Dr. Kazemian, program director of EP Fellowship at Deborah Heart and Lung Center. “This is a significant leap forward for the community of robotic electrophysiologists and we look forward to the positive impact its expanded use will have on our patients and the EP field.”

Stereotaxis develops surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat more than 150,000 patients in the United States, Europe, Asia, and elsewhere.